In the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.
Sadaf Emad-Vaez, PharmD Candidate
Advertisement
Articles by Sadaf Emad-Vaez, PharmD Candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Orforglipron Reduces Body Weight Up to 14% in Women at Every Stage of Menopause
2
Staging the Heart: NLA and EAS Reveal a New Era of Precision Lipidology and Imaging
3
Managing Grade 1 CRS in Patients With Follicular Lymphoma on Bispecific Antibodies: Home vs Health Care Facility Referred
4
First-Ever Guideline on Cardio-Kidney-Metabolic Syndrome Calls for Earlier Screening, Coordinated Care
5